Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Horikoshi

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Cancer Research|October 19, 2001
Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinaseC M Bradbury, S Markovina, S J Wei, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1982
[Clinical effects of human fibroblast interferon on malignant tumors]K Ezaki, K Okabe, J Inagaki, et al.
Anti-Cancer Drugs|November 26, 1999
Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study GroupA Sato, M Kurihara, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1984
[A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma]K Ikeda, M Ogawa, J Inagaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Wild-type p53 binds to the TATA-binding protein and represses transcriptionE Seto, A Usheva, G P Zambetti, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer]K Shinagawa, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[A study to overcome drug resistance using high-dose chemotherapy with autologous bone marrow transplantation]T Mukaiyama, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer]K Imajo, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Therapeutic difference by TAE between HCC with HCV-Ab and HBV-Ag]E Ninomiya, K Ohhashi, Y Murakami, et al.
Rinsho Hoshasen. Clinical Radiography|October 1, 1985
[Primary malignant lymphoma of the digestive system]T Nakajima, S Ishikawa, T Takahashi, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Cancer Research|October 19, 2001
Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinaseC M Bradbury, S Markovina, S J Wei, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1982
[Clinical effects of human fibroblast interferon on malignant tumors]K Ezaki, K Okabe, J Inagaki, et al.
Anti-Cancer Drugs|November 26, 1999
Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study GroupA Sato, M Kurihara, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1984
[A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma]K Ikeda, M Ogawa, J Inagaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Wild-type p53 binds to the TATA-binding protein and represses transcriptionE Seto, A Usheva, G P Zambetti, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer]K Shinagawa, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[A study to overcome drug resistance using high-dose chemotherapy with autologous bone marrow transplantation]T Mukaiyama, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer]K Imajo, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Therapeutic difference by TAE between HCC with HCV-Ab and HBV-Ag]E Ninomiya, K Ohhashi, Y Murakami, et al.
Rinsho Hoshasen. Clinical Radiography|October 1, 1985
[Primary malignant lymphoma of the digestive system]T Nakajima, S Ishikawa, T Takahashi, et al.
Pageof 14